These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 386320)

  • 41. Antibody-mediated rejection: treatment alternatives and outcomes.
    Singh N; Pirsch J; Samaniego M
    Transplant Rev (Orlando); 2009 Jan; 23(1):34-46. PubMed ID: 19027615
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antibodies to T cells in patients with systemic lupus erythematosus can induce antibody-dependent cell-mediated cytotoxicity against human T cells.
    Kumagai S; Steinberg AD; Green I
    J Clin Invest; 1981 Mar; 67(3):605-14. PubMed ID: 6970750
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Induction of bone marrow allograft rejection and hybrid resistance in nonresponder recipients by antibody: is there evidence for a dual receptor interaction in acute marrow graft rejection?
    Dennert G; Anderson CG; Warner J
    J Immunol; 1986 Jun; 136(11):3981-6. PubMed ID: 3517162
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The role of cytotoxic T lymphocytes in corneal allograft rejection.
    Hegde S; Niederkorn JY
    Invest Ophthalmol Vis Sci; 2000 Oct; 41(11):3341-7. PubMed ID: 11006223
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Monitoring of rejection.
    Stiller CR; Sinclair NR
    Transplant Proc; 1979 Mar; 11(1):343-9. PubMed ID: 377654
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Possible association of donor blood group A with higher alloantibody responses after renal transplantation.
    Halloran PF; Aprile M; Haddad G; Robinette M
    Transplantation; 1983 Mar; 35(3):255-8. PubMed ID: 6340278
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cellular and humoral immunity after allogeneic renal transplantation in the rat. V. Appearance of anti-idiotypic antibody and its relationship to cellular immunity after treatment with donor spleen cells and alloantibody.
    Stuart FP; Scollard DM; McKearn TJ; Fitch FW
    Transplantation; 1976 Nov; 22(5):455-66. PubMed ID: 11579
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Superiority of in vitro nondonor-specific immune monitoring over donor-specific assays in detecting a prerejection state.
    Kirchoff C; McGeorge M; Thomas FT; Mendez-Picon G; Thomas JM; Lower RR; Lee HM
    Surg Forum; 1979; 30():297-9. PubMed ID: 120020
    [No Abstract]   [Full Text] [Related]  

  • 49. A membrane permeability test for the detection of cell surface antigens.
    Kurth R; Medley G
    Immunology; 1975 Nov; 29(5):803-11. PubMed ID: 127743
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Complement and cell-mediated specific destruction of human endothelial cells treated with anti-DRw antisera.
    Hirschberg H; Moen T; Thorsby E
    Transplant Proc; 1979 Mar; 11(1):776-8. PubMed ID: 377711
    [No Abstract]   [Full Text] [Related]  

  • 51. Cellular presensitization to alloantigens in haemodialyzed patients.
    Gluckman JC; Gluckman E; Andersen E; Rottembourg J
    Transplantation; 1977 Jan; 23(1):65-72. PubMed ID: 65034
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunologic monitoring in the diagnosis of renal allograft rejection.
    Gailiunas P; Suthanthiran M; Person A; Carpenter CB; Garovoy MR
    Transplant Proc; 1977 Dec; 9(4):1823-5. PubMed ID: 341443
    [No Abstract]   [Full Text] [Related]  

  • 53. Mechanism of lymphocyte-mediated cytolysis. The LMC cycle and its role in transplantation immunity.
    Berke G; Amos DB
    Transplant Rev; 1973; 17(0):71-107. PubMed ID: 4152005
    [No Abstract]   [Full Text] [Related]  

  • 54. Lymphocyte dependent antibody (LDA) test in renal transplanted patients.
    Wojtulewicz-Kurkus J; Podobińska I; Rowińska D; Lao M; Gutowska-Jablońska M; Orłowski T
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):991-5. PubMed ID: 373697
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunologic correlates of human renal allograft survival.
    Etheredge EE; Sicard GA; Anderson CB
    Transplant Proc; 1979 Mar; 11(1):354-9. PubMed ID: 377655
    [No Abstract]   [Full Text] [Related]  

  • 56. Anti-donor cell-mediated responses. Pretransplant lymphocyte-mediated cytotoxicity (LMC) and antibody-dependent cell-mediated cytotoxicity (ADCC) in kidney transplantation.
    Myburgh JA; Smit JA
    Transplant Proc; 1978 Jun; 10(2):425-7. PubMed ID: 354131
    [No Abstract]   [Full Text] [Related]  

  • 57. Cell-bound receptors for alloantigens on normal lymphocytes. II. Antialloantibody serum contains specific factors reacting with relevant immunocompetent T lymphocytes.
    Binz H; Lindenmann J; Wigzell H
    J Exp Med; 1974 Sep; 140(3):731-41. PubMed ID: 4153293
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Detection of anti-donor "Ia" antibodies: a strong correlate of rejection.
    Suthanthiran M; Gailiunas P; Fagan G; Strom TB; Carpenter CB; Garovoy MR
    Transplant Proc; 1978 Sep; 10(3):605-7. PubMed ID: 362643
    [No Abstract]   [Full Text] [Related]  

  • 59. Role of antibody to tubular basement membrane (TBM) antigen in kidney transplantation.
    Kashiwabara H; Wakashin Y; Benitani A; Oomori K; Hachisu T; Shishido H; Yokoyama T; Wakashin M; Iwasaki Y
    Transplant Proc; 1979 Mar; 11(1):434-7. PubMed ID: 377671
    [No Abstract]   [Full Text] [Related]  

  • 60. Target cell-substratum interaction. II. Complement-dependent antibody-induced inhibition of adherence.
    David GS; Wiglesworth CM
    J Immunol; 1977 Aug; 119(2):500-3. PubMed ID: 328775
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.